Form 8-K MoonLake Immunotherapeut For: Jul 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
MoonLake Immunotherapeutics raises $30M as underwriters exercise overallotment option
July 15, 2026 6:04 AM EDTMoonLake Immunotherapeutics (NASDAQ: MLTX) received $30.0 million in additional gross proceeds after underwriters exercised their overallotment option in full, according to a company statement.
The underwriters exercised their option on July 10, 2026, to purchase an additional 1,500,000 Class A ordinary shares at a par value... More
